Biolevate

Biolevate announced its €30M Series A funding co-led by RAISE France and Orange Ventures, with participation from MSD GHI Fund, STATION F, and EQT Ventures & Growth.
They partnered with industry leaders like Sanofi and ecosystem champions like Microsoft to deploy evidence-grade AI platform across impactful life sciences workflows, with 16x faster research synthesis, 80% efficiency gains in regulatory intelligence.